Literature DB >> 14758919

Liposuction in arm lymphedema treatment.

H Brorson1.   

Abstract

Breast cancer is the most common disease in women, and up to 38% develop lymphedema of the arm following mastectomy, standard axillary node dissection and postoperative irradiation. Limb reductions have been reported utilizing various conservative therapies such as manual lymph and pressure therapy. Some patients with long-standing pronounced lymphedema do not respond to these conservative treatments because slow or absent lymph flow causes the formation of excess subcutaneous adipose tissue. Previous surgical regimes utilizing bridging procedures, total excision with skin grafting or reduction plasty seldom achieved acceptable cosmetic and functional results. Microsurgical reconstruction involving lympho-venous shunts or transplantation of lymph vessels has also been investigated. Although attractive in concept, the common failure of microsurgery to provide complete reduction is due to the persistence of newly formed subcutaneous adipose tissue, which is not removed in patients with chronic non-pitting lymphedema. Liposuction removes the hypertrophied adipose tissue and is a prerequisite to achieve complete reduction. The new equilibrium is maintained through constant (24-hour) use of compression garments postoperatively. Long-term follow up (7 years) does not show any recurrence of the edema.

Entities:  

Mesh:

Year:  2003        PMID: 14758919     DOI: 10.1177/145749690309200409

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  26 in total

1.  Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.

Authors:  Jamie C Zampell; Sonia Elhadad; Tomer Avraham; Evan Weitman; Seth Aschen; Alan Yan; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

Review 2.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

3.  Lymphedema.

Authors:  Stanley G Rockson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

4.  Update on the biology and treatment of lymphedema.

Authors:  Stanley G Rockson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

Review 5.  The Lymphatic Vasculature: Its Role in Adipose Metabolism and Obesity.

Authors:  Noelia Escobedo; Guillermo Oliver
Journal:  Cell Metab       Date:  2017-08-24       Impact factor: 27.287

Review 6.  The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.

Authors:  Guillermo Oliver; Jonathan Kipnis; Gwendalyn J Randolph; Natasha L Harvey
Journal:  Cell       Date:  2020-07-23       Impact factor: 41.582

Review 7.  Lymphatic lipid transport: sewer or subway?

Authors:  J Brandon Dixon
Journal:  Trends Endocrinol Metab       Date:  2010-06-11       Impact factor: 12.015

Review 8.  Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.

Authors:  Mei R Fu
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 9.  Lymphedema secondary to melanoma treatments: diagnosis, evaluation, and treatments.

Authors:  Azuelos Arié; Takumi Yamamoto
Journal:  Glob Health Med       Date:  2020-08-31

10.  An Integrative Therapeutic Concept for Surgical Treatment of Severe Cases of Lymphedema of the Lower Extremity.

Authors:  Jurij Kiefer; Georgios Koulaxouzidis; G Björn Stark; Etelka Foeldi; Nestor Torio-Padron; Vincenzo Penna
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.